Bank Of Baroda Share Price

Overview

Bank Of Baroda share price is currently ₹225.38, up by ₹1.18 (0.53%) from its previous closing price of ₹224.20. The share price has declined -5.33% over the past month and declined -8.42% over the past year. The stock's 52-week low and high are ₹221.51 and ₹323.36, respectively. Bank Of Baroda has a market capitalisation of ₹ 1,20,000.00 Cr. The share price was last updated on 29 Sep 2026, 03:55 PM IST.

Bank Of Baroda
Bank Of Baroda
BANKBARODA
 ₹0.00
 ₹1.18
0.53%
Bank
 ₹0.00(%)1D

Updated: 29 Sep 2026, 03:55:14 pm IST

Market Data

Open Price

 ₹225.22

Prev. Close

 ₹224.20
 ₹221.51

Day Low

 ₹228.29

Day High

 ₹221.51

52 Week Low

 ₹323.36

52 Week High

BankBank - Public
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

6.43

Sector PE

12.22

PB Ratio

0.70

Sector PB

1.67

EPS

35.07

Dividend Yield

3.43

Today's Volume

8.036 M

5 Day Avg. Volume

5.389 M

PEG Ratio

-1.53

Market Cap.

₹ 1,20,000.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 425% at ₹8.5/Share
05-Jun-202605-Jun-2026
DividendsFinal Dividend of 417.5% at ₹8.35/Share
06-Jun-202506-Jun-2025

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
HDFC Small Cap Fund - Regular Plan - Growth4.68 Cr
4.68 Cr
no change
HDFC Balanced Advantage Fund - Growth3.00 Cr
3.00 Cr
no change
Kotak Multi Cap Fund - Regular Plan - Growth-
2.77 Cr
(100%)
Kotak Arbitrage Fund - Growth1.74 Cr
2.33 Cr
(33.84%)
SBI Balanced Advantage Fund - Regular Plan - Growth2.16 Cr
2.16 Cr
no change

About Bank Of Baroda 👋

The Bank of Baroda Limited is an India-based bank engaged in providing banking and financial services in India. Its segments include Treasury, Corporate / Wholesale Banking, Retail Banking, and Other Banking Operations. Its geographical segment includes Domestic Operations and Foreign Operations. It offers personal banking services, which include savings accounts, current accounts, and term deposits. It offers a range of loans, such as home loans, vehicle loans, personal loans, baroda yoddha loans for defense personnel, education loans, other loans, gold loans and mortgage loans. It offers a range of insurance, such as general insurance, life insurance, and standalone health insurance. Its products include Accounts, Digital Banking Products, Loans and Digital Loans. Its business products include Corporate Banking and Agriculture. Its Accounts products include saving accounts, current accounts and fixed deposit. The Bank has approximately 8,648 domestic branches.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Ravi Bhatt

Ravi Bhatt

22 Sep • 11:56 AM · SEBI-Registered Analyst

BANKNIFTY TECHNICAL LEVEL & DERIVATIVE ANALYSIS

BANKNIFTY BULLISH BREAKOUT ZONE 56500 BANKNIFTY BEARISH BREAKOUT ZONE 56000 OPEN INTEREST UPDATES IN OPTION CHAIN: HIGHER OPEN INTEREST SEEN @ 56500 CALL & 56000 PUT. AS PER DATA ANALYSIS MARKET LOOKS RANGE BOUND. AS PER OPTION CHAIN ANALYSIS 56500 LOOKS STRONG RESISTANCE LEVEL AND 56000 IS KEY SUPPORT LEVEL. BANKNIFTY PUT CALL RATIO IS 0.89. PUT CALL RATIO INDICATES CALL OPTION SELLERS ARE DOMINATING MARKET. TODAY STLL PRIVATE BANKS ARE LOOKING GOOD COMPARE TO PUBLIC SECTOR BANKS. HEAVY PROFIT BOOKING SEEN IN PUBLIC SECTOR BANKS SPECIALLY IN BANK OF BARODA, AND PNB. POSITIONAL TRADER CAN TAKE LONG POSITION AFTER 56500 LEVEL AND SHORT OPPORTUNITY WILL CREATE IF BANKNIFTY BREAK 56000 LEVEL.

HDFCBANK

See More
CA ATIN AGRRAWAL

CA ATIN AGRRAWAL

21 Sep • 2:34 PM · SEBI-Registered Analyst

bank of baroda near to demand zone good to accumulate

BANKBARODA
Bank of Baroda (BANKBARODA) closed at ₹234.94 on 18 September 2026. Technically, the stock is currently sitting in an important zone. The broader moving-average structure remains cautious, with the 20-day EMA around ₹238 and the 50-day EMA around ₹245. 📊 Technical view Immediate resistance: ₹238–241 Major resistance: ₹244–245 Above ₹245: sustained closing could improve the technical structure. Immediate support: ₹231–232 Next support: ₹228–229 Below ₹231: weakness can increase towards ₹228 and ₹225. The important point for me is that ₹238–245 is the confirmation zone. Until the stock convincingly crosses this area, I would avoid assuming that a sustainable uptrend has started. 🏦 Fundamental perspective The Q1 FY27 numbers need to be read carefully. Net profit fell 72% YoY to ₹1,278 crore because of a one-time ₹5,700 crore NMC Health settlement. Excluding this exceptional item, reported profit would have been ₹5,528 crore. NII, however, grew 9.5% YoY to ₹12,524 crore. Domestic advances grew 16% YoY, while domestic deposits grew 14.7%, showing continued balance-sheet growth. At the same time, NIM was 2.77% and GNPA stood at 1.99%, so margins and asset quality remain important factors to monitor. My SEBI RA-style view ₹231–232 is the key support zone, while ₹238–245 is the important resistance/confirmation zone. For an investor, I would focus on price action around these levels rather than chasing the stock in the middle of the range. A sustained breakout above ₹245 would change the technical setup positively; conversely, a decisive breakdown below ₹231 would indicate increasing technical weakness. This is my market commentary based on available technical and fundamental information, not a guarantee of returns. Investors should consider their own risk profile, investment horizon and portfolio allocation.

See More
Manjushri Sharma SEBI RA

Manjushri Sharma SEBI RA

18 Sep • 2:51 PM · SEBI-Registered Analyst

BANKBARODA : SUPPLY ZONE NEEDS ATTENTION

BANKBARODA
closed at ₹232.30 down 1.14% on 16 September 2026. The stock is currently showing a supply-side order block which is an important area to watch from a technical perspective. In simple terms a supply zone is an area where selling pressure has previously entered the market. When price comes back towards this zone sellers may become active again. That is why I would closely watch the price behaviour around the supply area rather than looking at the one-day fall in isolation. The recent performance also shows that the stock has seen some strong monthly moves. After a 4% decline in August the stock recovered with a 1.5% gain in September so far. This makes the reaction around the supply zone even more important. My approach here would be simple: watch the price reaction at supply and look for confirmation through volume and price structure. If the stock fails to sustain above the zone and selling pressure increases the supply area could become an important resistance. On the other hand a decisive breakout with strong participation would indicate that sellers are being absorbed. For me the key point is not the -1.14% move today but whether the supply zone continues to attract sellers. Supply tells us where selling may appear. Price action tells us whether sellers are actually in control. Market observation for information sharing only. Not investment advice.

See More
Pyrifera Investment Advisors

Pyrifera Investment Advisors

15 Sep • 10:35 PM · SEBI-Registered Analyst

Mangalam Drugs Faces Prolonged ₹15.57 Crore Default

Mangalam Drugs and Organics Limited continues to grapple with severe liquidity constraints, reporting ongoing defaults on its revolving working capital facilities totaling ₹15.57 crore as of mid-July 2026. Key Highlights: Default Details: The overdue amount includes ₹9.51 crore to Bank of Maharashtra and ₹6.06 crore to Bank of Baroda. The default has persisted for nearly 11 months (since October 2025), with balances continuously exceeding sanctioned drawing power. Q1 FY27 Financials: The company showed marginal operational improvement, narrowing its standalone net loss by ~45% YoY to ₹7.55 crore (from ₹13.73 crore). However, operating revenue remained stagnant at ₹57.12 crore. Strategic Risks & Market Implications: Credit & NPA Threat: The prolonged duration of the default places the company’s credit rating under severe pressure and significantly increases the risk of lenders classifying the accounts as Non-Performing Assets (NPAs) or initiating recovery actions. Operational Bottleneck: This persistent working capital gap restricts access to fresh credit, which could eventually disrupt raw material procurement and hamper production volumes at the company’s critical Vapi API manufacturing facility. Outlook: While management has made progress in cost control and inventory management to narrow losses, the systemic liquidity crisis remains unresolved. An urgent debt restructuring package or fresh equity infusion is critical to restore banking relationships, normalize working capital cycles, and safeguard ongoing manufacturing operations.

MANGALAM

See More
Mayank Kumar

Mayank Kumar

13 Sep • 8:46 PM · SEBI-Registered Analyst

Bank of Baroda (BoB) has a strong underlying banking

BANKBARODA
1. Strong loan growth: Global advances are growing faster than deposits, with retail loans particularly strong. Management has subsequently raised its FY27 growth forecast to around 7–7.2% for the economy, which supports the broader banking outlook. 2. Funding advantage: BoB recently mobilised around $8 billion through FCNR(B) deposits, substantially above its initial $4–5 billion target. This gives the bank additional funding flexibility. 3. Asset quality is improving: GNPA and NNPA are substantially lower YoY, while credit cost has fallen. This is important because continued asset-quality improvement can support earnings even if NIMs remain under pressure. 4. Digital transformation: BoB is increasing investment in technology and cybersecurity and has launched bob World 2.0 with voice-banking capabilities. The bank is also using AI in customer service and credit/collections. 🔴 Risks The biggest near-term issue is NIM pressure. Global NIM declined to 2.77% from 2.91% YoY, so deposit/loan repricing will remain important.

See More
Sumit Kadam

Sumit Kadam

12 Sep • 11:08 AM · SEBI-Registered Analyst

NSE IPO: A Lower Price, But a Bigger Story.

IPO pricing reflects market conditions, valuation and demand—not just past unlisted prices; investors should study fundamentals before drawing conclusions. Imagine the market as a giant auction. A year ago, NSE’s unlisted shares touched nearly **₹2,400**. Today, its IPO price band is **₹1,700–₹1,785**—about **26% below that peak**. The IPO opens September 17. So, what changed? The market changed. NSE is coming with an **Offer for Sale**, meaning existing shareholders are selling shares rather than NSE raising fresh capital. The issue has also been reduced to about **₹22,569 crore** at the upper band. But here comes the interesting part for **Nifty 500 investors**. NSE has several listed shareholders that could benefit from value unlocking. The names worth studying include: **

SBIN
** **Bank of Baroda (BANKBARODA)** **General Insurance Corporation of India (GICRE)** **The New India Assurance Company (NIACL)** **United India Insurance Company (UIIC)** Reports estimate that listed shareholders collectively hold NSE stakes potentially worth around **₹95,000 crore** at ₹1,785 per share. The lesson is bigger than one IPO: When a privately held asset gets listed, **hidden value can become visible**. But visible value is not automatically cash in the bank. Investors should examine ownership, accounting value, eventual monetisation, valuation and business fundamentals before treating it as a benefit. **Educational purpose only — not a stock tip, recommendation or investment advice. Please conduct your own research and consult a SEBI-registered investment professional where appropriate.**

See More

News & Events

Frequently Asked Questions

What is the share price of Bank Of Baroda?

What is the market cap of Bank Of Baroda?

Should I buy Bank Of Baroda stock now?

What is the 52 week high and low of Bank Of Baroda?

Is the Bank Of Baroda stock good to buy?

Is Bank Of Baroda a good buy for the long term?

Is Bank Of Baroda overvalued or undervalued?

What is the PE and PB ratio of Bank Of Baroda?

Start Now